21. This system categorises renal cell carcinoma with grades 1, 2, 3, 4 based on nuclear characteristics. 22. In 2007, mTORC1 inhibitors began being approved for treatments against cancers such as renal cell carcinoma . 23. In June 2000, Shawn was diagnosed with renal cell carcinoma ( cancer of the kidneys ). 24. The company's lead cancer product is in late-stage clinical trials for the treatment of renal cell carcinoma . 25. Oxford BioMedica began patient recruitment in a Phase III trial in renal cell carcinoma in November 2006. 26. It has been approved for renal cell carcinoma and soft tissue sarcoma by numerous regulatory administrations worldwide. 27. Walsh was diagnosed with a rare form of cancer known as renal cell carcinoma in June 2000. 28. Is an experimental anti-S1P monoclonal antibody that has had a phase II clinical trial for renal cell carcinoma . 29. Their designation was slightly altered by Fetter to the now widely accepted term " Renal Cell Carcinoma ". 30. A phase II clinical trials were started investigating ZD6126 in metastatic renal cell carcinoma and metastatic colorectal cancer.
